Association Between ACE2 and Lung Diseases

DOI: https://doi.org/10.2147/idr.s445180

2024-05-07

Infection and Drug Resistance

Abstract:Cheng Su, 1, &ast Cai Li, 2, &ast Xinyi Hu, 3, &ast Jing Wang, 1, &ast Linlin Liu, 4, &ast Xianfeng Zhang, 4 Yeqing Tong 4 1 School of Public Health, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China; 2 Infectious Disease Prevention and Control Center, Wuhan Center for Disease Control and Prevention, Wuhan, Hubei, People's Republic of China; 3 Global Study Institute, University of Geneva, Geneva, 1205, Switzerland; 4 Infectious Disease Prevention and Control Center, Hubei Center for Disease Control and Prevention, Wuhan, Hubei, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yeqing Tong; Xianfeng Zhang, Email ; Angiotensin-converting enzyme 2 (ACE2) is an important regulator of the Renin-Angiotensin System (RAS). Additionally, it has been identified as a functional receptor for the Coronavirus. Research indicates that ACE2 plays a role in the regulation of cardiovascular systems by modulating blood pressure and electrolyte balance. Its role in pulmonary diseases has also garnered significant attention due to the widespread prevalence of Coronavirus. There is solid evidence linking ACE2 to other pulmonary diseases, including chronic obstructive pulmonary disease, acute respiratory distress syndrome, allergic asthma, among others. However, the exact pathological and physiological mechanisms of ACE2 in these diseases remain elusive. Our research aims to review and explore the latest advancements in ACE2-related studies in pulmonary diseases. These findings have the potential to open new avenues for utilizing ACE2 as a potential biomarker for early diagnosis and monitoring of pulmonary diseases. Keywords: ACE2, lung diseases, ARDS, Lung Cancer, COPD Angiotensin-converting enzyme 2 (ACE2) was discovered 20 years ago. 1 It is the main regulator of Renin-Angiotensin System (RAS), plays a crucial regulatory role by converting inactive angiotensin I (AngI) into the vasoconstrictor angiotensin II (AngII), 2 which is the central effector molecule of the RAS system. AngII mediates numerous biological responses through angiotensin receptors (AT1 and AT2). ACE2, a homologue of ACE, can cleave AngII into the peptide Ang1-7 (Figure 1). It has protective effects on the heart, vasodilation, anti-growth, and anti-proliferation properties, and it can also enhance the activity of bradykinin. 3 In addition, ACE2 has multiple functions, including the transportation of amino acids and serving as a functional receptor for the severe acute respiratory syndrome (SARS) and other coronavirus diseases. 4,5 These functions have gained significant attention in recent years. Figure 1 Schematic representation of classical RAS and the counter-regulating RAS axis. First reported to express in the heart, kidney, and testis, the ACE2 gene has since been found to be more extensively expressed in the upper respiratory tract, lung, intestinal tract, and liver (Figure 2). 6 The tissue distribution study of the ACE2 gene indicates that it is primarily concentrated in type II alveolar cells and macrophages in the respiratory system, but it is also present in lung fibroblasts, bronchial and tracheal epithelial cells, and macrophages. 6,7 The main entrance point for Coronavirus is ACE-2. 8 Heart failure (HF), pulmonary hypertension (PH), myocardial infarction (MI), and cardiovascular consequences of diabetes are all demonstrated in laboratory models of human disease to involve ACE2. 9 Figure 2 Distribution of ACE2 expression. Due to the high expression of the ACE2 gene in various tissues and organs, as well as its ability to regulate the self-functional properties of the RAS system, ACE2 can modulate multiple pathological processes in the body, such as fibrosis, inflammation, oxidative stress, and vasoconstriction. Studying the changes in ACE2 gene expression may provide valuable insights into the susceptibility and complications of pulmonary diseases, as well as the pathogenic mechanisms associated with risk factors for pulmonary diseases. For example, environmental factors such as smoking can increase the expression of ACE2, 10,11 and smoking is a well-established risk factor for many pulmonary diseases. In certain pulmonary diseases such as chronic obstructive pulmonary disease (COPD), ACE2 is overexpressed in the alveolar and bronchial epithelium. 12 It can be speculated that smoking increases the risk of developing pulmonary diseases by affecting ACE2 expression. The expression of ACE2 can be regulated through various mechanisms, incl -Abstract Truncated-

pharmacology & pharmacy,infectious diseases